Table Of Contents:
Chapter 1. Research Methodology and Scope
- Market Segmentation and Scope
- Regional Coverage
- Objectives
- Research Methodology
Chapter 2. Executive Summary
- Market Landscape
- Market Size & Forecast
- Competitive Landscape
Chapter 3. Acute Ischemic Stroke (AIS) Market: By Product Type
- Thrombectomy Devices Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Thrombectomy Devices Definitions, Technology Landscape
- Thrombectomy Devices Market Drivers
- Product Launches
- Technology Launches
- Growing adoption of minimally invasive interventions
- Thrombectomy Devices Market Restraints
- High cost of advanced thrombectomy devices
Chapter 4. Acute Ischemic Stroke (AIS) Market: By End-User
- Hospitals Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Hospitals Definitions, Technology Landscape
- Hospitals Market Drivers
- Increasing prevalence of stroke
- Advancements in stroke diagnostics
- Hospitals Market Restraints
- Shortage of skilled healthcare professionals
Chapter 5. Acute Ischemic Stroke (AIS) Market: By Stroke Type
- Ischemic Stroke Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Ischemic Stroke Definitions, Technology Landscape
- Ischemic Stroke Market Drivers
- Rising awareness about prompt stroke treatment
- Integration of digital health solutions
- Ischemic Stroke Market Restraints
- Regulatory and reimbursement challenges
Chapter 6. Acute Ischemic Stroke (AIS) Market: By Patient Age
- Geriatric (65 years and above) Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Geriatric (65 years and above) Definitions, Technology Landscape
- Geriatric (65 years and above) Market Drivers
- Expanding geriatric population
- Advancements in stroke rehabilitation
- Geriatric (65 years and above) Market Restraints
- Limited access to stroke care in certain regions
Chapter 7. Acute Ischemic Stroke (AIS) Market: By Treatment Approach
- Thrombolytic Therapy Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Thrombolytic Therapy Definitions, Technology Landscape
- Thrombolytic Therapy Market Drivers
- Increasing adoption of combination therapies
- Expanding indications for existing treatments
- Thrombolytic Therapy Market Restraints
- Risk of complications and side effects
Chapter 8. Acute Ischemic Stroke (AIS) Market: Regional Market Trends, Size, and Future Outlook
- North America Market Size (US$), CAGR (%), and Forecast (2021-2031)
- North America Definitions, Technology Landscape
- North America Market Drivers
- High prevalence of stroke
- Well-established healthcare infrastructure
- North America Market Restraints
- Reimbursement challenges for advanced treatments
- Europe Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Europe Definitions, Technology Landscape
- Europe Market Drivers
- Aging population
- Increasing adoption of minimally invasive interventions
- Europe Market Restraints
- Limited access to stroke care in certain regions
- Asia Pacific Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Asia Pacific Definitions, Technology Landscape
- Asia Pacific Market Drivers
- Rising stroke incidence
- Improving healthcare infrastructure
- Asia Pacific Market Restraints
- High treatment costs
- Latin America Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Latin America Definitions, Technology Landscape
- Latin America Market Drivers
- Expanding awareness about stroke management
- Increasing healthcare investments
- Latin America Market Restraints
- Limited availability of specialized stroke care
- Middle East & Africa Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Middle East & Africa Definitions, Technology Landscape
- Middle East & Africa Market Drivers
- Growing geriatric population
- Improving stroke care infrastructure
- Middle East & Africa Market Restraints
- Shortage of skilled healthcare professionals
Acute Ischemic Stroke (AIS) Market: Competitive Landscape
- Medtronic plc
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Stryker Corporation
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Johnson & Johnson
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Penumbra, Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Terumo Corporation
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Koninklijke Philips N.V.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Genentech, Inc. (Roche)
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Boehringer Ingelheim GmbH
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Bristol-Myers Squibb Company
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Pfizer Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Bayer AG
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Daiichi Sankyo Company, Limited
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Biogen Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Sanofi S.A.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Merck & Co., Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
Research Methodology
- Primary Research
- Secondary Research
- Assumptions
- IDataAcumen Analysis
- Paid Databases
Appendix
- About Us
Frequently Asked Questions
The current market size of the Acute Ischemic Stroke (AIS) industry is estimated to be US$ 8,450 million as of 2023.
The key factors contributing significantly to the growth of the Acute Ischemic Stroke (AIS) market include the rising prevalence of stroke, the growing geriatric population, advancements in stroke diagnostics, and the development of innovative treatment options.
The key factors hampering the growth of the Acute Ischemic Stroke (AIS) market include the high cost of stroke treatment devices and medications, limited access to stroke care in certain regions, the risk of complications and side effects with stroke therapies, and reimbursement challenges for advanced stroke treatments.
The leading component segment in the Acute Ischemic Stroke (AIS) Market is the thrombectomy devices segment, which is used to mechanically remove blood clots from the brain and restore blood flow.
The major players operating in the Acute Ischemic Stroke (AIS) Market include Medtronic plc, Stryker Corporation, Johnson & Johnson, Penumbra, Inc., Terumo Corporation, Koninklijke Philips N.V., Genentech, Inc. (Roche), Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, and Pfizer Inc.
The Acute Ischemic Stroke (AIS) Market is expected to grow at a CAGR of 8.7% from 2023 to 2030, reaching a market size of US$ 16,470 million by 2031.
The key drivers of the Acute Ischemic Stroke (AIS) Market include the rising incidence of stroke, the growing geriatric population, advancements in stroke diagnostics, the development of innovative treatment options, and the increasing adoption of minimally invasive stroke interventions.